📊🇺🇸 EARNINGS — THURSDAY, OCTOBER 29

The major companies reporting before the market opened delivered mostly positive results, although the market was demanding about some of their outlooks.

💊 🟢 Eli Lilly ($LLY)
Very strong results, driven by the strength of Mounjaro and Zepbound. It beat expectations and raised its full-year guidance.

💳 🟢 Mastercard ($MA)
A good quarter, with sustained growth in cross-border payments and value-added services. Results exceeded forecasts.

🧬 🟢 Merck ($MRK)
Positive results, supported by oncology and progress from its newer medicines. The company also improved its outlook.

🚜 🟡 Caterpillar ($CAT)
Reported record sales, improved margins, and a very large order backlog. However, its outlook did not entirely convince the market.

🛢 🟢 Shell ($SHEL)
A strong quarter, with solid cash generation, debt reduction, and a new share buyback program.

🏭 🟡 Linde ($LIN)
Beat forecasts and achieved record figures, though it struck a cautious tone about the outlook for the European economy.

🎯 SUMMARY: A favorable day for corporate earnings, with Eli Lilly, Mastercard, Merck, and Shell standing out in particular. Caterpillar and Linde posted good numbers, but received a more demanding market response.

#FedWatch